▸
▾
Claim This Listing
Please login in order to be able to claim this listing.
You are not currently logged in. Please login or register first. When registering, you will receive an activation email. Be sure to check your spam if you don’t see it in your email within 60 minutes.
Login
OxSonics Ltd.
OxSonics® aims to provide a drug-class-agnostic solution to the greatest challenge in oncological drug delivery: the inability of therapeutic agents to effectively penetrate solid tumours.
The SonoTran® drug delivery platform is designed for the oncology ward and can be used seamlessly with a broad range of current and future therapeutic agents aimed at treating solid tumours. The technique is equally applicable to already marketed and investigational therapeutic agents through partnerships with oncology drug developers. SonoTran utilizes a purely mechanical effect, triggered by ultrasound applied non-invasively, to actively transport therapeutics throughout tumours without the need for drug reformulation. The same device not only enhances but also enables mapping of the drug delivery process, confirming that the treatment is being successfully applied to the target tissues in real time.
